Skip to content

Publication

ASCO-Friends Cancer Clinical Trials Eligibility Criteria

August 8, 2018

Publication

2021 Scientific Report

March 16, 2022

Publication

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group

May 1, 2021

Publication

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Washout Period and Concomitant Medication Work Group

May 1, 2021

Publication

Peer Review | Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO–Friends of Cancer Research Prior Therapies Work Group

May 1, 2021

News

AgencyIQ — FDA finalizes guidances on cancer trial eligibility criteria

July 28, 2026

Publication

Peer Review | Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group

May 1, 2021

Publication

Peer Review | Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO–Friends of Cancer Research Joint Research Statement

May 1, 2021

News

RAPS: Regulatory Focus — FDA finalizes three guidances to broaden cancer clinical trial eligibility

July 27, 2026

Publication

White Paper | 2016 Annual Meeting | Report and Issue Briefs

December 12, 2016

Publication

2020 Scientific Report

April 7, 2021

Publication

2022 Scientific Report

February 15, 2023

News

Pink Sheet — New Cancer Clinical Trial Guidances Continue US FDA Push For Expanded Eligibility

July 27, 2026

Project Page

Policy Priorities

Publication

2019 Scientific Report

March 30, 2020